Share this article on:

Integrated Strategies for Combination HIV Prevention: Principles and Examples for Men Who Have Sex With Men in the Americas and Heterosexual African Populations

Celum, Connie MD, MPH*,†; Baeten, Jared M. MD, PhD*,†; Hughes, James P. PhD; Barnabas, Ruanne MD*; Liu, Albert MD, MPH§; Van Rooyen, Heidi PhD; Buchbinder, Susan MD§

JAIDS Journal of Acquired Immune Deficiency Syndromes: July 1st, 2013 - Volume 63 - Issue - p S213–S220
doi: 10.1097/QAI.0b013e3182986f3a
Supplement Article

Abstract: Combination HIV prevention is of high priority for increasing the impact of partially efficacious HIV prevention interventions for specific populations and settings. Developing the package requires critical review of local epidemiology of HIV infection regarding most-impacted populations and those at high risk of HIV transmission and acquisition, drivers of HIV infection, and available interventions to address these risk factors. Interventions should be considered in terms of the evidence basis for efficacy, potential synergies, and feasibility of delivery at scale, which is important to achieve high coverage and impact, coupled with high acceptability to populations, which will impact uptake, adherence, and retention. Evaluation requires process measures of uptake, adherence, retention, and outcome measures of reduction in HIV infectiousness and acquisition. Three examples of combination prevention concepts are summarized for men who have sex with men in the Americas, young women in sub-Saharan Africa, and HIV serodiscordant couples.

Departments of *Global Health and Medicine,

Epidemiology, and

Biostatistics, University of Washington, Seattle, WA;

§San Francisco Department of Public Health, Department of Medicine, University of California, San Francisco, San Francisco, CA; and

Human Sciences Research Council, Durban, South Africa.

Correspondence to: Connie Celum, MD, MPH, International Clinical Research Center, Department of Global Health, University of Washington, Box 359927, 325 Ninth Avenue, Seattle, WA 98104 (e-mail:

Supported by the National Institutes of Health grants (R01 AI083034, R01 AI083034-02S2, R01AI083060-04), Directors Award (RC4 AI092552), and HIV Prevention Trials Network grants (UM1 AI068619).

The authors have no conflicts of interest to disclose.

© 2013 Lippincott Williams & Wilkins, Inc.